Infosys has escalated its legal battle against Cognizant by filing a counterclaim accusing Cognizant and CEO Ravi Kumar of anti-competitive tactics to hinder its Helix healthcare platform. Infosys alleges Cognizant obstructed Helix’s development, restricted access to training programs, and misused confidential information. This counters a 2024 lawsuit from Cognizant’s subsidiary claiming Infosys stole trade secrets for Helix.
Infosys has escalated its legal battle against Cognizant by filing a counterclaim accusing Cognizant and CEO Ravi Kumar of anti-competitive tactics to hinder its Helix healthcare platform. Infosys alleges Cognizant obstructed Helix’s development, restricted access to training programs, and misused confidential information. This counters a 2024 lawsuit from Cognizant’s subsidiary claiming Infosys stole trade secrets for Helix. Infosys has escalated its legal battle against Cognizant by filing a counterclaim accusing Cognizant and CEO Ravi Kumar of anti-competitive tactics to hinder its Helix healthcare platform. Infosys alleges Cognizant obstructed Helix’s development, restricted access to training programs, and misused confidential information. This counters a 2024 lawsuit from Cognizant’s subsidiary claiming Infosys stole trade secrets for Helix. Read More
About The Author
